An iatrogenic orphan?

Research output: Contribution to journalReview article

Abstract

In this issue of Blood, Wang and colleagues from the Mayo Clinic and the University of Iowa, describe the outcomes of patients diagnosed with diffuse large B-cell lymphoma (DLBCL) and treated in the era of rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) who are also found to have an underlying indolent lymphoma in the lymph nodes or the bone marrow.

Original languageEnglish
Pages (from-to)1273-1274
Number of pages2
JournalBlood
Volume134
Issue number16
DOIs
StatePublished - Oct 17 2019

Fingerprint Dive into the research topics of 'An iatrogenic orphan?'. Together they form a unique fingerprint.

  • Cite this